Radcliffe Capital Management’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-66,566
| Closed | -$672K | – | 830 |
|
|
2022
Q4 | $672K | Sell |
66,566
-100
| -0.2% | -$1.01K | 0.02% | 752 |
|
|
2022
Q3 | $661K | Hold |
66,666
| – | – | 0.02% | 1021 |
|
|
2022
Q2 | $653K | Hold |
66,666
| – | – | 0.02% | 1075 |
|
|
2022
Q1 | $651K | Hold |
66,666
| – | – | 0.01% | 1078 |
|
|
2021
Q4 | $647K | Hold |
66,666
| – | – | 0.02% | 943 |
|
|
2021
Q3 | $649K | Hold |
66,666
| – | – | 0.02% | 797 |
|
|
2021
Q2 | $647K | Buy |
+66,666
| New | +$647K | 0.02% | 817 |
|